Navigation Links
AcelRx Pharmaceuticals to Host Investor Day on June 27, 2013
Date:6/21/2013

REDWOOD CITY, Calif., June 21, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, will host an Investor Day on Thursday, June 27, 2013, from 9:00 a.m. to 11:00 a.m. EDT (6:00 a.m. to 8:00 a.m. PDT) at the 21 Club, 21 West 53rd Street, New York, NY.

Members of the AcelRx management team will present insights on the Company's Sufentanil NanoTab PCA System Phase 3 clinical trial results and discuss plans related to hospital formulary adoption and commercialization. In addition, thought leaders who treat post-operative pain in the hospital setting will discuss their experience with and perspectives on the Sufentanil NanoTab PCA System. Breakfast will be served for meeting attendees from 8:00 a.m. to 9:00 a.m. and a link to the live webcast will be available on the Investors page of the Company's website at www.acelrx.com beginning at 9:00 a.m. EDT. An archive of the webcast will be available shortly after the event through the Investors page at www.acelrx.com.

About AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.  AcelRx's lead product candidate, the Sufentanil NanoTab PCA System, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the complexity of infusion pumps. The NanoTab System has
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
2. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
3. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
4. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
5. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
6. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
7. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
8. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
9. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. AcelRx Pharmaceuticals Provides Clinical Trial Updates
11. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 ... für kongestive Herzinsuffizienz (CHF) in seiner ersten ...     Die israelische ... Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz (CHF) ... ein Finanzierungsvorhaben über 5 Mio. USD abgeschlossen ...
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015  Chiasma, ... its lead product for the orphan condition acromegaly, today ... financing round. Participants in the financing included new investors ... blue chip public investment fund, as well as existing ... Abingworth and ARCH Venture Partners. Chiasma ...
(Date:2/26/2015)... DALLAS , February 27, 2015 ... Review, H2 2014 market research report to its ... the Corneal Ulcers, therapeutic pipeline. The ... information on the therapeutic development for Corneal Ulcers. ... infections that includes bacterial infections, viral infections & ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
... A unique treatment involving the use of hot chemotherapy ... Center. SJH&MC is the first hospital in Southeast Michigan ... offer the treatment. Know as Hyperthermic Intraperitoneal ... number of advanced cancers that have spread to the ...
... and SYDNEY, Nov. 4, 2011 HeartWare International, Inc. ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that CEO Doug Godshall is scheduled to ... 11:00 a.m. MST on Wednesday, November 9, 2011.  The ...
Cached Medicine Technology:St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System 2HeartWare to Present at the Credit Suisse 2011 Healthcare Conference 2
(Date:2/28/2015)... 2015 Pioneer Millworks reclaimed USA wood ... & Construction Materials Show, an annual, premier sustainable building ... suppliers and top manufacturers of the latest building products, ... sourced and manufactured by Pioneer Millworks from their ... Japan at restaurants, hotels, retailers, and corporate offices. ...
(Date:2/28/2015)... A case management conference ( http://www.testosteronelawsuithub.com/ ... filed by law firms including Bernstein Liebhard LLP has ... Firm notes. , According to a Calendar posted ... litigation will meet on March 13, 2015 at 1:30 ... designed to raise levels of the male hormone. The ...
(Date:2/28/2015)... The noted Friedman Dental Group of ... officially relaunched their website. The new version of the ... a new section about their team members. Potential and ... biographies of each Friedman Dental Group team member including ... designed to provide our patients with the opportunity to ...
(Date:2/28/2015)... ” was featured on NewsWatch as part of its monthly ... coolest technology products and services available to consumers. Scott Steinberg, ... the review and shared with viewers how they provide a ... low battery and no way to charge a phone or ... basis. Even when a person does have a charger, sitting ...
(Date:2/28/2015)... My Shiney Hiney® LLC., the renowned brand in personal ... Nevada for the annual ASD Market Week tradeshow. , ... tradeshows and My Shiney Hiney will be one of the ... can be found at booth number C1663. , My Shiney ... hygiene brush and cleansing system exclusively created to clean and ...
Breaking Medicine News(10 mins):Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2
... as Australian scientists now look to honey as a solution, to ... Cook Hospital in Middlesbrough were inspired by the use of honey ... honey as a dressing for their wounds. , Mention ... such as the Charaka and Susrutha Samhitis, and the Bible as ...
... Delhi: Lt Gen Saibal Mukherjee has taken over as the ... ,An alumnus of Government Medical College, Nagpur he was ... obtaining MD in Radio Diagnosis from Pune University in 1977, ... Memorial Hospital, Mumbai and received MD from Bombay University. ...
... a pharmaceutical drug named Sunitinib in halting the ... of interferon and// sunitinib treatments found that sunitinib ... metastatic kidney cancer. ,The work was ... The New England Journal of Medicine and involved ...
... published in the March 1st issue of the journal ... are at increased risk for cardiovascular disease.// ... cardiovascular disease to heightened recognition and a rising prevalence. ... role in cardiovascular disease, particularly systemic hypertension. ...
... affect your judgment, suggests a new study.// ... brain function. Now William Killgore and colleagues at the ... Maryland, US, studied 26 healthy adults, all of whom ... found that sleep deprivation has a particularly debilitating effect ...
... The arrival of spring brings fragrant, blooming trees and lush ... people with pollen allergy.// ,Hay fever, or ... causes symptoms of sneezing, itchy and watery eyes, runny nose ... palate. Spring allergy is most commonly caused by tree and ...
Cached Medicine News:Health News:A New Drug for Halting Metastatic Kidney Cancer 2Health News:Sleep Well, Have a Healthy Heart ! 2Health News:Weather Forecasts Spring Pollen Allergy Severity 2
... 2 eyes, oral. Marked with recommended ... opaque line. Graduated. Single use. For ... kinking of the tube by incorporating ... to the anatomical situation at body ...
... Slick Set® Tube with stylet inside. ... quality uncuffed Rusch endotracheal tube with ... to use saving you time and ... coded for easy identification and has ...
... Rusch Safety Clear Plus™ Cuffed Endotracheal Tube ... stylet inside. Sterile, Single use. A quality Rusch ... ready to use saving you time and storage ... to facilitate smooth withdrawal. It is designed with ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Medicine Products: